In the BDL-induced mouse model of liver fibrosis, IL-22 was shown to increase collagen type I expression while significantly reducing α-SMA mRNA expression, suggesting its antifibrotic effect (53). This evidence concerns the gene ACTA1 and Hepatic fibrosis.